Role of Ligand-Based Drug Design Methodologies toward the Discovery of New Anti- Alzheimer Agents: Futures Perspectives in Fragment-Based Ligand Design
Keywords: Alzheimer's Disease (AD); Amyloid β -A4 Protein; Anti-AD Agents; Fragment-Based Drug Discovery; Glycogen Synthase Kinase-3β; Ligand-Based Drug Design; Linear Discriminant Analysis; Monoamine Oxidase B; Multi-Target Inhibitors; QSAR; Quantitative Contributions
Document Type: Research Article
Publication date: 2012-04-01
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.